Morphomic Analysis Group, University of Michigan, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Sci Rep. 2018 Jul 27;8(1):11369. doi: 10.1038/s41598-018-29825-5.
Measurements of skeletal muscle cross-sectional area, index, and radiation attenuation utilizing clinical computed tomography (CT) scans are used in assessments of sarcopenia, the loss of skeletal muscle mass and function associated with aging. To classify individuals as sarcopenic, sex-specific cutoffs for 'low' values are used. Conventionally, cutoffs for skeletal muscle measurements at the level of the third lumbar (L3) vertebra are used, however L3 is not included in several clinical CT protocols. Non-contrast-enhanced CT scans from healthy kidney donor candidates (age 18-40) at Michigan Medicine were utilized. Skeletal muscle area (SMA), index (SMI), and mean attenuation (SMRA) were measured at each vertebral level between the tenth thoracic (T10) and the fifth lumbar (L5) vertebra. Sex-specific means, standard deviations (s.d.), and sarcopenia cutoffs (mean-2 s.d.) at each vertebral level were computed. Associations between vertebral levels were assessed using Pearson correlations and Tukey's difference test. Classification agreement between different vertebral level cutoffs was assessed using overall accuracy, specificity, and sensitivity. SMA, SMI, and SMRA L3 cutoffs for sarcopenia were 92.2 cm, 34.4 cm/m, and 34.3 HU in females, and 144.3 cm, 45.4 cm/m, and 38.5 HU in males, consistent with previously reported cutoffs. Correlations between all level pairs were statistically significant and high, ranging from 0.65 to 0.95 (SMA), 0.64 to 0.95 (SMI), and 0.63 to 0.95 (SMRA). SMA peaks at L3, supporting its use as the primary site for CT sarcopenia measurements. However, when L3 is not available alternative levels (in order of preference) are L2, L4, L5, L1, T12, T11, and T10. Healthy reference values reported here enable sarcopenia assessment and sex-specific standardization of SMA, SMI, and SMRA in clinical populations, including those whose CT protocols do not include L3.
利用临床计算机断层扫描(CT)扫描测量骨骼肌的横截面积、指数和辐射衰减,用于评估与衰老相关的骨骼肌减少症,即骨骼肌质量和功能的丧失。为了将个体分类为肌少症患者,使用了“低值”的性别特异性截止值。传统上,使用第三腰椎(L3)水平的骨骼肌测量的截止值,但是 L3 并不包含在几个临床 CT 方案中。利用密歇根大学医学中心的健康肾脏供体候选人(年龄 18-40 岁)的非增强 CT 扫描。在 T10 到 L5 椎体之间的每个椎体水平测量骨骼肌面积(SMA)、指数(SMI)和平均衰减(SMRA)。计算了每个椎体水平的性别特异性平均值、标准差(s.d.)和肌少症截止值(平均值-2 s.d.)。使用 Pearson 相关性和 Tukey 差异检验评估椎体水平之间的相关性。使用总准确性、特异性和敏感性评估不同椎体水平截止值之间的分类一致性。女性 SMA、SMI 和 SMRA L3 肌少症截止值分别为 92.2cm、34.4cm/m 和 34.3HU,男性分别为 144.3cm、45.4cm/m 和 38.5HU,与之前报道的截止值一致。所有水平对之间的相关性均具有统计学意义且高度相关,范围从 0.65 到 0.95(SMA)、0.64 到 0.95(SMI)和 0.63 到 0.95(SMRA)。SMA 在 L3 处达到峰值,支持将其作为 CT 肌少症测量的主要部位。然而,当 L3 不可用时,替代水平(按优先顺序)为 L2、L4、L5、L1、T12、T11 和 T10。此处报告的健康参考值可用于在临床人群中评估肌少症并对 SMA、SMI 和 SMRA 进行性别特异性标准化,包括那些 CT 方案不包含 L3 的人群。